UnitedHealth Group Incorporated (UNH)

UnitedHealth Group's stock price has declined, with a share price of $309.11 as of June 27, 2025, representing a 39.30% decrease from June 28, 2024. Key events impacting the stock include the cyberattack on Change Healthcare, which resulted in significant recovery costs and antitrust concerns. The company also revised its full-year 2025 earnings outlook downward due to higher-than-anticipated care activity and changes in Optum Health member profiles. Additionally, the company has faced class-action lawsuits and a Department of Justice probe.

Demand seasonality is a factor in UnitedHealth Group's operations, with actuarial models accounting for seasonal variances in medical care consumption. Seasonal health trends contribute to heightened care activity, particularly within UnitedHealthcare's Medicare Advantage businesses, impacting earnings.

UnitedHealth Group, Inc. is an American multinational for-profit company specializing in health insurance and healthcare services. The company operates within the managed healthcare and insurance sectors through two segments: UnitedHealthcare and Optum. UnitedHealthcare provides health benefit plans and services to various clients, including employers, individuals, and those served through Medicare and state programs. Optum focuses on healthcare services, including medication management, healthcare services, and health information technology, serving over 100 million individuals.

UnitedHealth Group's operations extend globally, serving over 52 million people worldwide. While deeply entrenched in the U.S. healthcare system, the company has a presence in various countries, including South America, Brazil (though its operations in Brazil were sold in February 2024), India, Ireland, the Philippines, and the United Kingdom.

UnitedHealth Group's brand reputation has been negatively impacted by the cyberattack on Change Healthcare, leading to recovery costs and data security concerns. The company has faced regulatory and legal investigations, lawsuits, and fines related to stock option backdating, Medicare overbilling, unfair claims practices, mental health treatment denials, and anticompetitive behavior. Shareholder scrutiny and public outrage have arisen due to concerns about healthcare costs, restricted access, and the company's practices that limit or delay access to healthcare.

UnitedHealth Group's stock ownership is a mix of institutional, retail, and individual investors. Approximately 73.42% of the company's stock is owned by institutional investors, while 0.18% is held by insiders, and 26.40% by public companies and individual investors. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and State Street Corp.